Kiran
Sheffrin

Ms. Sheffrin’s clients have included AmerisourceBergen, Anheuser‑Busch InBev, Avon, BDT, Cincinnati Bell, Conduent, DRI Capital, Eurazeo, IBM, Lindsay Goldberg, New Senior, Parker Hannifin, RELX Group, Unilever, Valvoline and Viatris.

Ms. Sheffrin was named a “Rising Star” by Law360 in 2024, recognizing her as one of five outstanding tax lawyers in the nation under the age of 40, and in 2023, she was shortlisted for the “Rising Star: Tax” award at Euromoney Legal Media Group’s Americas Women in Business Law Awards.

Ms. Sheffrin’s notable transactions include representing:

• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;

• Anheuser-Busch InBev in its $123 billion acquisition of SABMiller and the $12 billion sale of SABMiller’s U.S. and global Miller-branded businesses to Molson Coors and an asset swap with Ambev in which AB InBev transferred SABMiller’s Panamanian business to Ambev and Ambev transferred its business in Colombia, Peru and Ecuador to AB InBev;

• Artel in its acquisition by Advanced Instruments;

• Avon in its $3.7 billion acquisition by Natura and Avon North America in its $125 million acquisition by LG Household and Healthcare;

• BDT and its affiliates in connection with multiple matters, including the acquisition of a majority interest in Alliance Laundry Systems from Ontario Teachers’ Pension Plan;

• Cincinnati Bell in its $2.9 billion acquisition by Macquarie Infrastructure, its $650 million combination with Hawaii Telecom and its $201 million acquisition of OnX Enterprise Solutions;

• Conduent in the sale of its commercial vehicle operations business to Alinda Capital Partners and the sale of its U.S.-based human resource consulting and actuarial business to H.I.G. Capital;

• Dentsu Aegis in its acquisition of Merkle;

• DRI Capital and its affiliates in connection with DRI Healthcare Trust’s acquisition of a royalty interest in Orserdu from Eisai, its acquisition of a second royalty interest in Orserdu from Radius Health, the $210 million sale of its TZIELD royalty interest to Sanofi and two offerings of units totaling C$201.7 million;

• Eurazeo in its acquisition of Scaled Agile;

• Fortress in the sale of its remaining 40.5% equity interest in OneMain Holdings to an investor group led by Apollo Global Management and Värde Partners;

• The Fresh Market in its $1.36 billion sale to affiliates of Apollo;

• GasLog in its take‑private transaction with BlackRock’s Global Energy & Power Infrastructure Fund;

• IBM in numerous transactions, including its acquisitions of the Adobe Workfront consultancy, Agile 3 solutions, BoxBoat Technologies, the technology assets from Catalogic Software, Databand.ai, McD Tech Labs from McDonald’s, Polar Security, Randori, ReaQta and Sentaca;

• Lindsay Goldberg and American Securities in the $2.405 billion acquisition of AECOM’s Management Services business, as well as Lindsay Goldberg in its acquisitions of Fleetwood-Fibre Packaging & Graphics and Allpak Container;

• New Senior in its $2.3 billion acquisition by Ventas;

• the underwriters in the IPO of On Holding;

• Orbotech in its $3.4 billion sale to KLA‑Tencor;

• Parker Hannifin in its $3.67 billion acquisition of LORD;

• RELX Group in its £580 million acquisition of ThreatMetrix, its acquisition of Safe Banking Systems and its acquisition of Aries Systems;

• Route Mobile and its founding shareholders in the pending ₹59.22 billion sale of a majority stake in Route Mobile to Proximus Group;
• Spectranetics in its €1.9 billion sale to Phillips;

• Unilever in its $384 million acquisition of TAZO from Starbucks, its acquisition of Seventh Generation and its acquisition of Sundial Brands;

• Valvoline in the $2.65 billion sale of its Global Products business to Aramco;

• Viatris in its divestitures totaling $6.94 billion in value, including the $3.335 billion combination of its biosimilars portfolio with Biocon Biologics and the divestitures of its Over‑the‑Counter, Women’s Healthcare and Active Pharmaceutical Ingredients businesses, and in the $750 million acquisitions of Oyster Point and Famy Life Sciences, as well as Mylan in its $50 billion combination with Upjohn, a division of Pfizer, to form Viatris, its $9.9 billion acquisition of Meda, its $5.6 billion inversion acquisition of Abbott Laboratories’ non‑U.S. developed markets specialty and branded generics business, its acquisition of the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing plus additional contingent payments of up to $50 million and its proposal to acquire Perrigo in a transaction valued at approximately $35 billion; and

• Vista Outdoor in its acquisition of Camp Chef.

Ms. Sheffrin was born in Princeton, New Jersey and grew up in Davis, California. She received a B.A. from Wesleyan University in 2010 and a J.D. magna cum laude from Brooklyn Law School in 2013, where she was an Associate Managing Editor of the Journal of International Law and a member of the Moot Court Honor Society. Following her graduation, Ms. Sheffrin served as a law clerk to the Hon. Ralph K. Winter of the U.S. Court of Appeals for the Second Circuit.

Ms. Sheffrin joined Cravath in 2014 and was elected of counsel in 2023.